Wells Fargo’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-71,779
| Closed | -$15.6M | – | 7884 |
|
|
2021
Q1 | $15.6M | Sell |
71,779
-39,624
| -36% | -$7.45M | ﹤0.01% | 1868 |
|
|
2020
Q4 | $12.9M | Buy |
111,403
+679
| +0.6% | +$76.1K | ﹤0.01% | 1889 |
|
|
2020
Q3 | $10.8M | Buy |
110,724
+12,495
| +13% | +$1.44M | ﹤0.01% | 1846 |
|
|
2020
Q2 | $12.1M | Buy |
98,229
+9,628
| +11% | +$1.09M | ﹤0.01% | 1710 |
|
|
2020
Q1 | $7.76M | Sell |
88,601
-20,975
| -19% | -$2.22M | ﹤0.01% | 1872 |
|
|
2019
Q4 | $11.5M | Buy |
109,576
+11,699
| +12% | +$1.31M | ﹤0.01% | 1874 |
|
|
2019
Q3 | $11.3M | Sell |
97,877
-159,633
| -62% | -$24.2M | ﹤0.01% | 1858 |
|
|
2019
Q2 | $44.4M | Buy |
257,510
+17,108
| +7% | +$2.96M | 0.01% | 980 |
|
|
2019
Q1 | $40.5M | Sell |
240,402
-48,356
| -17% | -$7.2M | 0.01% | 1014 |
|
|
2018
Q4 | $28.1M | Sell |
288,758
-18,420
| -6% | -$2.42M | 0.01% | 1168 |
|
|
2018
Q3 | $53.1M | Buy |
307,178
+35,022
| +13% | +$5.05M | 0.02% | 902 |
|
|
2018
Q2 | $38M | Buy |
272,156
+242,984
| +833% | +$34.5M | 0.01% | 1068 |
|
|
2018
Q1 | $3.29M | Buy |
29,172
+4,987
| +21% | +$627K | ﹤0.01% | 2961 |
|
|
2017
Q4 | $3.19M | Buy |
24,185
+4,549
| +23% | +$535K | ﹤0.01% | 2990 |
|
|
2017
Q3 | $1.99M | Buy |
19,636
+5,674
| +41% | +$608K | ﹤0.01% | 3317 |
|
|
2017
Q2 | $1.4M | Buy |
13,962
+2,500
| +22% | +$269K | ﹤0.01% | 3477 |
|
|
2017
Q1 | $1.39M | Buy |
11,462
+1,063
| +10% | +$130K | ﹤0.01% | 3492 |
|
|
2016
Q4 | $1.16M | Buy |
10,399
+641
| +7% | +$77.2K | ﹤0.01% | 3581 |
|
|
2016
Q3 | $1.29M | Buy |
9,758
+3,589
| +58% | +$343K | ﹤0.01% | 3296 |
|
|
2016
Q2 | $565K | Sell |
6,169
-541
| -8% | -$45.5K | ﹤0.01% | 3842 |
|
|
2016
Q1 | $484K | Sell |
6,710
-1,183
| -15% | -$64.9K | ﹤0.01% | 3884 |
|
|
2015
Q4 | $549K | Sell |
7,893
-291,631
| -97% | -$23.8M | ﹤0.01% | 3863 |
|
|
2015
Q3 | $27.4M | Buy |
299,524
+2,269
| +0.8% | +$252K | 0.01% | 1089 |
|
|
2015
Q2 | $36.5M | Sell |
297,255
-9,319
| -3% | -$1.06M | 0.01% | 973 |
|
|
2015
Q1 | $27.9M | Sell |
306,574
-9,645
| -3% | -$783K | 0.01% | 1118 |
|
|
2014
Q4 | $21.4M | Sell |
316,219
-14,808
| -4% | -$1.08M | 0.01% | 1238 |
|
|
2014
Q3 | $26.8M | Sell |
331,027
-4,385
| -1% | -$388K | 0.01% | 1080 |
|
|
2014
Q2 | $36M | Buy |
335,412
+12,372
| +4% | +$860K | 0.01% | 949 |
|
|
2014
Q1 | $19.2M | Buy |
323,040
+322,740
| +107,580% | +$19.2M | 0.01% | 1292 |
|
|
2013
Q4 | $12K | Buy |
+300
| New | +$9.49K | ﹤0.01% | 5158 |
|
Other funds holding GWPH
Wells Fargo's GWPH Position: Q2 2021 in Review
Wells Fargo sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 71,779 shares — an estimated $15.6M sold.
Wells Fargo first reported a position in GWPH in Q4 2013 and held it in 30 quarters. The position peaked at $53.1M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Wells Fargo reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Wells Fargo sold 71,779 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $15.6M.
- Wells Fargo first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 30 quarters.
- Wells Fargo's GW Pharmaceuticals Plc American Depositary Shares position peaked at $53.1M in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Wells Fargo's 13F filing for Q2 2021, filed 16 Aug 2021.